CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

SABSSAB Biotherapeutics, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $3.17 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$288.43M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-18 · Kropotova Alexandra (CHIEF MEDICAL OFFICER) · OTHER
  • 2026-03-25 · Kropotova Alexandra (CHIEF MEDICAL OFFICER) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders89
Shares held70,258,952
Value$273.49M
Percent of shares outstanding77.22%
As of quarter end2026-06-30
RECENT NEWS
  • SAB Biotherapeutics to present SAB-142 data at EASD meeting
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
SAB Biotherapeutics, Inc. (SABS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit